Orphenadrine Citrate
规格
4682-36-4CAS 号
225-137-5EC 号
N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acidIUPAC 名称
C24H31NO8化学式
461.5 g/mol分子量
Orphenadrine citrate; 4682-36-4; Banflex; Flexon; Orphenadrine dihydrogen citrate; Orphenadrine (Citrate); X-Otag; Flexoject; DTXSID8044678; NSC-757238; X0A40N8I4S; Orphenadrine citrate (USP); Orphenadrine citrate [USP]; CHEBI:7790; DTXCID6024678; Citrate, Orphenadrine; Orphenadrine Citrate ER; RefChem:55784; 225-137-5; Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1); Norflex; Orphenadrine citrate salt; 4596-23-0; 2-hydroxypropane-1,2,3-tricarboxylic acid; dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine; N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid; NCGC00094745-01; Plenactol; Flexor; Tega-Flex; Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-,2-hydroxy-1,2,3-propanetricarboxylate (1:1); N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid; Norflex (pharmaceutical); CAS-4682-36-4; EINECS 225-137-5; UNII-X0A40N8I4S; Orphenadrine citrate; (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate; Norflex (TN); Orphenadrine citrate CRS; N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1); N,N-Dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate; Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); MLS000069549; SCHEMBL119470; SPECTRUM1500447; Orphenadrine citrate (Norflex); HY-B0369AR; orb1222237; orb1300611; CHEMBL1200395; SCHEMBL29369316; HMS502K15; HY-B0369A; MSK14446X; ORPHENADRINE CITRATE [MI]; MMMNTDFSPSQXJP-UHFFFAOYSA-N; HMS1920D10; HMS2091L10; HMS2231J06; HMS3259M21; HMS3370M12; HMS3651A10; HMS3884M22; HMS5080H21; Orphenadrine (citrate) (Standard); Pharmakon1600-01500447; ORPHENADRINE CITRATE [VANDF]; Tox21_111323; Tox21_113543; Tox21_301079; CCG-40242; EBC-11114; MFCD00079197; N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine Citrate Salt; NSC757238; ORPHENADRINE CITRATE [MART.]; ORPHENADRINE CITRATE [WHO-DD]; AKOS008132385; Tox21_111323_1; FO26587; NC00525; NSC 757238; (+-)-N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1); Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-, citrate (1:1); NCGC00015771-13; NCGC00094745-02; NCGC00094745-03; NCGC00254980-01; AS-74807; DA-66372; Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, (+-)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); ORPHENADRINE CITRATE [EP IMPURITY]; ORPHENADRINE CITRATE [ORANGE BOOK]; SMR000058817; ORPHENADRINE CITRATE [EP MONOGRAPH]; ORPHENADRINE CITRATE [USP MONOGRAPH]; NS00082653; SW102176-4; T6618; EN300-53019; NORGESIC COMPONENT ORPHENADRINE CITRATE; C75247; D00774; INVAGESIC COMPONENT ORPHENADRINE CITRATE; ORPHENGESIC COMPONENT ORPHENADRINE CITRATE; SR-01000002975-5; INVAGESIC FORTE COMPONENT ORPHENADRINE CITRATE; ORPHENGESIC FORTE COMPONENT ORPHENADRINE CITRATE; Q27107584; Z234896463; N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate; (+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate; (+/-)-N,N-DIMETHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1); 3-carboxy-3,5-dihydroxy-5-oxo-pentanoate;dimethyl-[2-[o-tolyl(phenyl)methoxy]ethyl]ammonium; N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate; (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]- ethanamine dihydrogen 2-hydroxypropane-1,2,3- tricarboxylate; 2-Hydroxypropane-1,2,3-tricarboxylic acid--N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethan-1-amine (1/1); ETHANAMINE, N,N-DIMETHYL-2-((2-METHYLPHENYL)PHENYLMETHOXY)-, (+/-)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1); N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylate同义词
